Shruti Jolly, MD

Articles

ACR Appropriateness Criteria® Adjuvant Management of Early-Stage Endometrial Cancer

Andrew O. Wahl, MD;David K. Gaffney, MD, PhD;Anuja Jhingran, MD;Catheryn M. Yashar, MD;Matthew Biagioli, MD;Mohamed A. Elshaikh, MD;Shruti Jolly, MD;Elizabeth Kidd, MD;Larissa J. Lee, MD;Linna Li, MD;David H. Moore, MD;Gautam G. Rao, MD;Ned L. Williams, DO;William Small, Jr, MD

September 15th 2016

After a review of the published literature, the panel voted on three variants to establish best practices for the utilization of imaging, radiotherapy, and chemotherapy after primary surgery for early-stage endometrial cancer.

ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer

Shruti Jolly, MD;Payal Soni, MD;David K. Gaffney, MD, PhD;Matthew Biagioli, MD;Mohamed A. Elshaikh, MD;Anuja Jhingran, MD;Elizabeth Kidd, MD;Larissa J. Lee, MD;Linna Li, MD;David H. Moore, MD;Gautam G. Rao, MD;Andrew O. Wahl, MD;Ned L. Williams, DO;Catheryn M. Yashar, MD;William Small, Jr, MD

November 16th 2015

The panel reviewed the pertinent literature in vulvar cancer and voted on three variants to establish appropriate use of imaging, adjuvant radiation, including dose, fields, and technique, as well as adjuvant chemotherapy. This report will aid clinicians in selecting appropriate patients for adjuvant treatment and will provide guidelines for the optimal delivery of adjuvant radiation therapy and chemotherapy.